The maillard or browning reaction in diabetes

A major pathophysiological consequence of hyperglycae­ mia is the extensive chemical interaction of glucose with proteins, leading to its attachment to these proteins with­ out the aid of enzymes. Even though the Maillard reac­ tions have been of considerable interest to food chemists since the tum of the century,' it has only been relatively recently that attention has focused on non-enzymic glyca­ tion of proteins in vivo. Although non-enzymic glycation leading to formation of reversible Amadori products acts on many proteins throughout the body, it is less obvious how these products are related to the pathophysiology of diabetic complications. Recent efforts have focused on biologically important further products of the glycation reaction, which are derived slowly from the Amadori product following a sequence of further reactions and rearrangements? These compounds, in contrast to the Amadori product, are formed irreversibly resulting in accumulation on long-lived proteins; these have been called advanced glycation end (AGE) products.

[1]  A. Cerami,et al.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.

[2]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[3]  J. Rousseaux,et al.  Evidence for an increased glycation of IgG in diabetic patients. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[4]  M. Cohen,et al.  Nonenzymatic Glycosylation of Basement Membranes: In Vitro Studies , 1981, Diabetes.

[5]  A. Bassiouny,et al.  Glucosylated Collagen Is Antigenic , 1983, Diabetes.

[6]  H. Wieland,et al.  Glycosylation of serum albumin: Elevated glycosyl‐albumin in diabetic patients , 1979, FEBS letters.

[7]  C. Elmets,et al.  Glycation of Skin Collagen in Type I Diabetes Mellitus: Correlation With Long-Term Complications , 1986, Diabetes.

[8]  P. Higgins,et al.  Reaction of monosaccharides with proteins: possible evolutionary significance. , 1981, Science.

[9]  M. Cohen,et al.  Increased glycosylation of glomerular basement membrane collagen in diabetes. , 1980, Biochemical and biophysical research communications.

[10]  G. Jerums,et al.  Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat , 1991, Diabetes.

[11]  J. Cobby,et al.  Glucosylated albumin and its influence on salicylate binding. , 1982, Journal of pharmaceutical sciences.

[12]  E. Bakan,et al.  Glycosylation of nail in diabetics: possible marker of long-term hyperglycemia. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[13]  M. Khatami,et al.  Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation. , 1988, Life sciences.

[14]  D. Green,et al.  NONENZYMATIC GLYCATI0N OF HUMAN BLOOD PLATELET PROTEINS , 1989, Thrombosis and Haemostasis.

[15]  D. Das,et al.  Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. , 1989, Biochemical and biophysical research communications.

[16]  V. Monnier,et al.  Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue. , 1989, Connective tissue research.

[17]  金重 秀明 Nonenzymatic glycosylation of serum IgG and its effect on antibody activity in patients with diabetes mellitus , 1988 .

[18]  A. Cerami,et al.  Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Thijssen,et al.  A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[20]  Z. Makita,et al.  Radioreceptor Assay for Advanced Glycosylation End Products , 1991, Diabetes.

[21]  V. Monnier,et al.  Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. , 1989, The Journal of biological chemistry.

[22]  H. Bunn,et al.  Nonenzymatic glycosylation of human serum albumin alters its conformation and function. , 1984, The Journal of biological chemistry.

[23]  Stephen J. Angyal,et al.  The composition of reducing sugars in solution , 1984 .

[24]  S. Wolff,et al.  Is glucose the sole source of tissue browning in diabetes mellitus? , 1990, FEBS letters.

[25]  L.,et al.  Glucosylation of human collagen in aging and diabetes mellitus. , 1980, The Journal of clinical investigation.

[26]  T. Lyons,et al.  Effect of Diabetes and Aging on Carboxymethyllysine Levels in Human Urine , 1991, Diabetes.

[27]  A. Cerami,et al.  Role of advanced glycosylation products in complications of diabetes. , 1988, Diabetes care.

[28]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[29]  V. Monnier,et al.  Collagen Aging In Vitro by Nonenzymatic Glycosylation and Browning , 1984, Diabetes.

[30]  C. Gerhardinger,et al.  Absence of Brown Product FFI in Nondiabetic and Diabetic Rat Collagen , 1990, Diabetes.

[31]  R. Kohn,et al.  Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. , 1981, The Journal of clinical investigation.

[32]  V. J. Stevens,et al.  Diabetic cataract formation: potential role of glycosylation of lens crystallins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Dominiczak,et al.  The Significance of the Products of the Maillard (Browning) Reaction in Diabetes , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[34]  S. Wolff,et al.  Protein glycation and oxidative stress in diabetes mellitus and ageing. , 1991, Free radical biology & medicine.

[35]  C. Elmets,et al.  Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. , 1986, The New England journal of medicine.

[36]  T. Lyons,et al.  Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[37]  A. Cerami,et al.  Advanced non-enzymatic tissue glycosylation: significance in late diabetic complications. , 1989, Diabetes research and clinical practice.

[38]  S. Pongor,et al.  Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. R. Holmquist,et al.  A new N-terminal blocking group involving a Schiff base in hemoglobin AIc. , 1966, Biochemistry.

[40]  J. Oram,et al.  Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated Cholesterol Efflux , 1991, Diabetes.

[41]  G. Kearns,et al.  Alteration of Phenytoin Binding by Glycosylation of Albumin in IDDM , 1987, Diabetes.

[42]  V. Monnier,et al.  End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. , 1990, The Journal of clinical investigation.

[43]  L. Morin,et al.  Nonenzymic glycation of human immunoglobulins does not impair their immunoreactivity. , 1989, Clinical chemistry.

[44]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[45]  P. Higgins,et al.  Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. , 1981, The Journal of biological chemistry.

[46]  G. Chandrakasan,et al.  Influence of monosaccharides on the fibrillogenesis of type I collagen. , 1989, Biochemical medicine and metabolic biology.

[47]  R H Haschemeyer,et al.  Oxygen-mediated heterogeneity of apo-low-density lipoprotein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Sampietro,et al.  Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo. , 1986, Clinical chemistry.

[49]  F. G. NjorogeS,et al.  Mechanism of Formation of the Putative Advanced Glycosylation End , 1988 .

[50]  J. Baynes,et al.  [8] Nonenzymatic glucosylation of lysine residues in albumin , 1984 .

[51]  The Fluorescence of Serum Proteins in Diabetic Patients with and without Retinopathy , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[52]  L. Furcht,et al.  Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus. , 1987, Biochemistry.

[53]  A. Burkhalter,et al.  Nonenzymatic glycation of immunoglobulins does not impair antigen-antibody binding. , 1987, Clinical chemistry.

[54]  A. Cerami,et al.  Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. , 1988, Diabetes/metabolism reviews.

[55]  K. Reiser,et al.  Nonenzymatic Glycation of Collagen in Aging and Diabetes , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[56]  J. Baynes,et al.  The Amadori product on protein: structure and reactions. , 1989, Progress in clinical and biological research.

[57]  H. Kunkel,et al.  New hemoglobin in normal adult blood. , 1955, Science.

[58]  J. Lunec,et al.  Role of Reactive Oxygen Species in the Generation of Fluorescence by Glycation , 1992, Annals of clinical biochemistry.

[59]  E. Friedman,et al.  Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.

[60]  R. Paisey,et al.  Glycosylation of hair: possible measure of chronic hyperglycaemia. , 1984, British medical journal.

[61]  J. Baynes,et al.  Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. , 1979, The Journal of biological chemistry.

[62]  R. Bucala,et al.  Detection of an advanced glycosylation product bound to protein in situ. , 1985, The Journal of biological chemistry.

[63]  O. Wieland,et al.  Increased Glycosylation of Serum Albumin in Diabetes Mellitus , 1980, Diabetes.

[64]  A. Cerami,et al.  Excessive Nonenzymatic Glycosylation of Peripheral and Central Nervous System Myelin Components in Diabetic Rats , 1983, Diabetes.

[65]  S. Srivastava,et al.  Activation of aldose reductase by nonenzymatic glycosylation. , 1989, Progress in clinical and biological research.

[66]  M. Brownlee,et al.  Glycosylation products as toxic mediators of diabetic complications. , 1991, Annual review of medicine.

[67]  R. Spiro,et al.  Nonenzymatic Glycation* of Basement Membranes From Human Glomeruli and Bovine Sources: Effect of Diabetes and Age , 1988, Diabetes.

[68]  K. Nicholls,et al.  Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[69]  J. Baynes,et al.  Nonenzymatic glucosylation of lysine residues in albumin. , 1984, Methods in enzymology.

[70]  R. Paisey,et al.  CORRELATION BETWEEN SKIN GLYCOSYLATION AND GLYCAEMIC CONTROL IN HUMAN DIABETES , 1984, Clinical endocrinology.

[71]  J. Baynes,et al.  Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.

[72]  P. Gallop,et al.  The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. , 1976, The Journal of clinical investigation.

[73]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.